PACB Earnings

Quarterly EPS
$-0.22
Q3 2024
$0.01
Q4 2024
$-1.44
Q1 2025
$-0.14
Q2 2025
$-0.13
Q3 2025
$-0.13
Q4 2025
$-0.03
Q1 2026
$-0.14
Q2 2026
Latest Revenue39.0M
Latest Net Income-44741000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.1439.0M-44741000-1.9%+0.0%
Q1 2026-$0.0337.2M-8275000+0.1%+97.9%
Q4 2025-$0.1344.6M-40371000+13.8%-1,400.0%
Q3 2025-$0.1338.4M-38000000-3.8%+40.9%
Q2 2025-$0.1439.8M-41930000+10.4%+78.1%
Q1 2025-$1.4437.2M-426075000-4.3%-396.6%
Q4 2024$0.0139.2M2.4M-32.8%+103.2%
Q3 2024-$0.2240.0M-60725000-28.2%+15.4%
Q2 2024-$0.6436.0M-173319000
Q1 2024-$0.2938.8M-78178000
Q4 2023-$0.3158.4M-82018000
Q3 2023-$0.2655.7M-66869000
Pacific Biosciences of California (PACB) — Earnings